Published on
November 26, 2025
- 16:30 GMT
Smartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in Hypercholesterolemia
MyTherapy now provides dedicated digital support for patients treated with Nustendi®, helping them stay adherent and reduce their cardiovascular risk. MUNICH , GERMANY, November 26, 2025 /EINPresswire.com/ -- Smartpatient, the company behind the MyTherapy platform, and Daiichi Sankyo, a global leader in cardiovascular medicine, have launched their first joint program to support patients living with high LDL cholesterol levels. Through a new, therapy-specific module in the MyTherapy app, the collaboration …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
